Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. COPD and Asthma Devices Market, by Region, 2018-2027 (USD Billion)
1.2.2. COPD and Asthma Devices Market, by Product Type, 2018-2027 (USD Billion)
1.2.3. COPD and Asthma Devices Market, by Indication, 2018-2027 (USD Billion)
1.2.4. COPD and Asthma Devices Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global COPD and Asthma Devices Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global COPD and Asthma Devices Market Dynamics
3.1. COPD and Asthma Devices Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global COPD and Asthma Devices Market: Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global COPD and Asthma Devices Market, by Product Type
5.1. Market Snapshot
5.2. Global COPD and Asthma Devices Market by Product Type, Performance - Potential Analysis
5.3. Global COPD and Asthma Devices Market Estimates & Forecasts by Product Type 2017-2027 (USD Billion)
5.4. COPD and Asthma Devices Market, Sub Segment Analysis
5.4.1. Inhalers
5.4.2. Nebulizers
Chapter 6. Global COPD and Asthma Devices Market, by Indication
6.1. Market Snapshot
6.2. Global COPD and Asthma Devices Market by Indication, Performance - Potential Analysis
6.3. Global COPD and Asthma Devices Market Estimates & Forecasts by Indication 2017-2027 (USD Billion)
6.4. COPD and Asthma Devices Market, Sub Segment Analysis
6.4.1. Asthma
6.4.2. Chronic Obstructive Pulmonary Disease (COPD)
Chapter 7. Global COPD and Asthma Devices Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global COPD and Asthma Devices Market by Distribution Channel, Performance - Potential Analysis
7.3. Global COPD and Asthma Devices Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Billion)
7.4. COPD and Asthma Devices Market, Sub Segment Analysis
7.4.1. Retail Pharmacies
7.4.2. Hospitals
7.4.3. Online Pharmacies
Chapter 8. Global COPD and Asthma Devices Market, Regional Analysis
8.1. COPD and Asthma Devices Market, Regional Market Snapshot
8.2. North America COPD and Asthma Devices Market
8.2.1.1. U.S. COPD and Asthma Devices Market
8.2.1.2. Product Type breakdown estimates & forecasts, 2017-2027
8.2.1.3. Indication breakdown estimates & forecasts, 2017-2027
8.2.1.4. Distribution Channel breakdown estimates & forecasts, 2017-2027
8.2.2. Canada COPD and Asthma Devices Market
8.3. Europe COPD and Asthma Devices Market Snapshot
8.3.1. U.K. COPD and Asthma Devices Market
8.3.2. Germany COPD and Asthma Devices Market
8.3.3. France COPD and Asthma Devices Market
8.3.4. Spain COPD and Asthma Devices Market
8.3.5. Italy COPD and Asthma Devices Market
8.3.6. Rest of Europe COPD and Asthma Devices Market
8.4. Asia-Pacific COPD and Asthma Devices Market Snapshot
8.4.1. China COPD and Asthma Devices Market
8.4.2. India COPD and Asthma Devices Market
8.4.3. Japan COPD and Asthma Devices Market
8.4.4. Australia COPD and Asthma Devices Market
8.4.5. South Korea COPD and Asthma Devices Market
8.4.6. Rest of Asia Pacific COPD and Asthma Devices Market
8.5. Latin America COPD and Asthma Devices Market Snapshot
8.5.1. Brazil COPD and Asthma Devices Market
8.5.2. Mexico COPD and Asthma Devices Market
8.6. Rest of The World COPD and Asthma Devices Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Aerogen, Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. AstraZeneca PLC
9.2.3. Baxter International Inc.
9.2.4. Boehringer Ingelheim International GmbH
9.2.5. 3M COMPANY
9.2.6. GF Health Products
9.2.7. GlaxoSmithKline Plc
9.2.8. Koninklijke Philips N.V.
9.2.9. Novartis AG
9.2.10. PARI medical Holding GMBH
9.2.11. Smith's Group Plc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption